Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer

Fig. 1

A tumor shadow was observed in the left hilum during the first visit to our department. Chemotherapy and radiotherapy were performed but terminated due to a decrease in performance status. The patient received no aggressive therapy, but the size of the tumor gradually decreased over one month. PD, progressive disease; BSC, best supportive care

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us